Cannabis Consequences 101

. 

The Quality Assurance and Patient Safety (QAPS) Committee has completed their Cannabis Consequences 101 series on overconsumption and has accredited it for 8 hour of continuing pharmacy education (CPE) credits. This 8 hour course is FREE for members as a thank you for your continued support. Our education is created by members and for members and we appreciate each and everyone of you! 

Register for Cannabis Consequences 101: Overconsumption -
FREE for members and $99 for non-members 

CE Accredited Education

ISO: Institutional Hospitals with Acute Cannabis Intoxication  

Anebulo Pharmaceuticals is conducting a study to understand the THC levels of patients visiting care facilities with Acute Cannabinoid Intoxication (ACI). This information is needed for the development of a CB1 antagonist that reverses ACI effects.
If your hospital sees ACI patients at least weekly, and your department is interested in participating in this study, please contact Linda to obtain more information: linda@anebulo.com

Seeking Volunteers for Observational Study 

AIMA, a vaginal health company, is transforming the lives of
menstruators by delivering their patent-pending formulation of CBD, CBG and other active agents locally to the vagina and uterus. AIMA targets a wide range of conditions, from period pain to pelvic pain. Their first product is a vaginal suppository for period pain: the OVY.  AIMA is seeking clinicians interested in recommending this vaginal suppository and is offering a free sample in exchange for completing a survey before and after use to be included in their observational study.
For more information, contact AIMA or visit their website. Please complete (or have your patients complete) their survey to obtain baseline symptoms. The survey is available on their website or the direct link is available here. 

Please note: this is not a sponsored post and ISCPh is voluntarily sharing this information with our membership to help obtain data on cannabis vaginal suppositories